BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21273976)

  • 1. Screening for ovarian cancer.
    Cragun JM
    Cancer Control; 2011 Jan; 18(1):16-21. PubMed ID: 21273976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for early detection of ovarian cancer.
    Nguyen L; Cardenas-Goicoechea SJ; Gordon P; Curtin C; Momeni M; Chuang L; Fishman D
    Womens Health (Lond); 2013 Mar; 9(2):171-85; quiz 186-7. PubMed ID: 23477323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for ovarian cancer.
    Jacobs I; Oram D
    Biomed Pharmacother; 1988; 42(9):589-96. PubMed ID: 3071382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer: screening and future directions.
    Gupta KK; Gupta VK; Naumann RW
    Int J Gynecol Cancer; 2019 Jan; 29(1):195-200. PubMed ID: 30640704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
    Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for ovarian cancer: what we know, what we need to know.
    Hensley ML; Castiel M; Robson ME
    Oncology (Williston Park); 2000 Nov; 14(11):1601-7; discussion 1608, 1613-6. PubMed ID: 11125943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early detection and preoperative diagnosis of ovarian carcinoma].
    Kainz C
    Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
    van der Velde NM; Mourits MJ; Arts HJ; de Vries J; Leegte BK; Dijkhuis G; Oosterwijk JC; de Bock GH
    Int J Cancer; 2009 Feb; 124(4):919-23. PubMed ID: 19035463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple biomarker panels for early detection of ovarian cancer.
    Yurkovetsky ZR; Linkov FY; E Malehorn D; Lokshin AE
    Future Oncol; 2006 Dec; 2(6):733-41. PubMed ID: 17155900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA 125 as a screening test for ovarian cancer.
    Hakama M; Stenman UH; Knekt P; Järvisalo J; Hakulinen T; Maatela J; Aromaa A
    J Med Screen; 1996; 3(1):40-2. PubMed ID: 8861050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalizing CA125 levels for ovarian cancer screening.
    Dorigo O; Berek JS
    Cancer Prev Res (Phila); 2011 Sep; 4(9):1356-9. PubMed ID: 21893498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.